Microbot Medical announced the first steps towards its planned European market clearance, by engaging with a leading Notified Body. The Notified Body will audit the Company to verify the compliance of its quality management system and the quality of the LIBERTY Robotic Surgical System development with widely acceptable standards in the medical device industry. In addition, preparations are being made to obtain EU-MDR certification leading to CE mark, which would allow the Company to sell the LIBERTY Robotic Surgical System throughout the European Union.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MBOT:
- Microbot Medical Engaging with a Leading Notified Body to Advance CE Mark for Sales in Europe
- Microbot Medical files to sell 2.28M shares of common stock for holders
- Microbot Medical appoints Bargellini to Scientific Advisory Board
- Microbot Medical completes extensive pre-clinical study performed in US
- Microbot Medical Raises a Total of $7.6 Million in Gross Proceeds from Four Recent Registered Direct Offerings